Results 251 to 260 of about 129,108 (303)

Myocardial Protection

Journal of Cardiac Surgery, 1986
Early studies of myocardial protection were designed to minimize ischemic injury. The next class and generation of investigations will most likely be designed to accelerate recovery following known myocardial injury. Such techniques will play an important role in allowing operations on acutely injured and ischemic myocardium and will be important in ...
A S, Wechsler, A S, Abd-Elfattah, C E, Murphy, D R, Salter, L A, Brunsting, J P, Goldstein   +5 more
openaire   +2 more sources

Myocardial protection and cardioplegia

Current Opinion in Cardiology, 1993
Over the past year there has been a tremendous enthusiasm for the novel technique of warm heart surgery. In contradistinction to hypothermic myocardial preservation, warm cardiac surgery provides for operative repair in a nonischemic heart. Warm cardioplegia can be administered in an antegrade or retrograde manner, continuously, and perhaps even ...
I B, Krukenkamp, S, Levitsky
openaire   +2 more sources

Myocardial protection for transplantation

Transplantation Proceedings, 1999
PROGRESS in the development of new techniques in surgery of heart transplantation had considerable influence on the creation of new methods for heart preservation. Currently, various cardioplegic solutions, developed for cardiac surgery, provide safe preservation of myocardial function for 5 to 6 hours, but remain unsatisfactory.
M, Garlicki, J, Kołcz, P, Rudziński, B, Kapelak, J, Sadowski, S, Wójcik, E, Pietrzyk, W, Frasik, J, Drukała, A, Dziatkowiak   +9 more
openaire   +2 more sources

Myocardial Protection with Carvedilol

Journal of Cardiovascular Pharmacology, 1992
Carvedilol is a multiple-action cardiovascular agent that is both a beta-adrenoceptor antagonist and a vasodilator and has recently been made available for the treatment of mild-to-moderate hypertension. Clinical trials are ongoing to establish the efficacy of carvedilol in angina and congestive heart failure. beta-Adrenoceptor antagonists are known to
G Z, Feuerstein, S A, Hamburger, E F, Smith, A, Bril, R R, Ruffolo   +4 more
openaire   +2 more sources

Melatonin and myocardial protection

International Journal of Cardiology, 2011
considerations. Circulation 2006;113:2335–62. [5] Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderiu X. Intraand interindividual biological variability data bank. Eur J Clin Chem Clin Biochem 1997;35:845–52. [6] Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC.
Ronit, Lavi, Shahar, Lavi
openaire   +2 more sources

Polarization and myocardial protection

Current Opinion in Cardiology, 1999
Heart surgery or transplantation generally involve global ischemia, and techniques have been developed to protect the myocardium from ischemic and reperfusion injury. Hyperkalemic cardioplegia has been the gold standard for myocardial protection for years, but patients undergoing surgery almost invariably have some postoperative dysfunction. One factor
openaire   +2 more sources

Pediatric myocardial protection

Current Opinion in Cardiology, 2008
Myocardial protection has contributed greatly to significant advances in pediatric cardiac surgery. New refinements in perfusion techniques and cardioplegia are under evaluation. Genetic factors are also promising tools to assess and improve myocardial protection.There is increasing doubt about the efficiency of hypothermia in preventing postoperative ...
openaire   +2 more sources

Advances in Myocardial Protection

The Journal of Cardiovascular Nursing, 1998
The success of cardiac surgery is due in large part to the myocardial protection techniques employed to maintain cardiac viability during the period of induced ischemic arrest. As the number of older, high-risk cardiac surgical patients increases, advances in myocardial protection have become necessary to achieve a quiet, bloodless operative field ...
openaire   +2 more sources

The future: therapy of myocardial protection

Annals of the New York Academy of Sciences, 2012
The main determinant of myocardial necrosis following an acute myocardial infarction (AMI) is duration of ischemia. Infarct size is a strong independent predictor of postinfarction mortality. Interventions able to protect the myocardium from death during an AMI (cardioprotection) are urgently needed.
David, Sanz-Rosa, Jaime, García-Prieto, Borja, Ibanez   +2 more
openaire   +2 more sources

Nifedipine: A myocardial protective agent

The American Journal of Cardiology, 1979
The effectiveness of the calcium antagonist nifedipine in preserving postischemic myocardial function and structural integrity was experimentally demonstrated in isolated rabbit hearts, in conscious dogs subjected to myocardial infarction, in open chest anesthetized dogs with normothermic regional ischemia induced for 1 to 2 hours and in dogs ...
R E, Clark, I Y, Christlieb, P D, Henry, A E, Fischer, J D, Nora, J R, Williamson, B E, Sobel   +6 more
openaire   +2 more sources